文献速递胃肠外科

荧光淋巴造影在微创全胃切除术中用于脾门淋巴结清扫的有效性

Fluorescent lymphography during minimally invasive total gastrectomy for gastric cancer: an effective technique for splenic hilar lymph node dissection.
PubMed 文献 · Surg Endosc · 2021-06-09

该回顾性研究分析了168例接受微创全胃切除+D2+No.10淋巴结清扫的胃癌患者,其中74例使用荧光淋巴造影(FL组),94例未使用(非FL组)。FL组脾门区 retrieved 淋巴结中位数更多(2.5 vs 1,P=0.012),对脾门淋巴结转移的阴性预测值为97.1%,且在无淋巴结转移患者中无复发生存率显著更高(100% vs 67.1%,P=0.017)。

要点

  • 荧光淋巴造影可增加脾门区淋巴结检出数目。
  • 对脾门淋巴结转移阴性预测值高(97.1%),有助于筛选可免除脾门清扫者。
  • 在无淋巴结转移患者中,使用荧光造影者无复发生存率显著更优。

核心结论

  • 荧光淋巴造影是微创全胃切除术中脾门区完整淋巴结清扫的有效工具,并可能帮助筛选无需脾门淋巴结清扫的患者。

研究设计与样本

  • 回顾性分析2013至2018年168例接受微创全胃切除+D2+No.10淋巴结清扫的胃癌患者,FL组74例,非FL组94例。

主要发现

  • FL组脾门区 retrieved 淋巴结中位数2.5(IQR 1-5)枚,非FL组1(IQR 1-3)枚,P=0.012。
  • 荧光淋巴造影对脾门淋巴结转移的阴性预测值为97.1%,敏感性为66.7%。
  • FL组与非FL组总生存率分别为96.9%与88.9%(P=0.334),无复发生存率分别为90.5%与65.5%(P=0.054),均无统计学差异。
  • 在无淋巴结转移患者中,FL组无复发生存率100%,非FL组67.1%,P=0.017。

临床怎么用

  • 在微创全胃切除术中可考虑使用荧光淋巴造影以增加脾门区淋巴结检出数目。
  • 荧光淋巴造影阴性预测值高,或可辅助判断哪些患者可安全省略脾门淋巴结清扫。

局限性

  • 回顾性研究设计,样本量有限,且荧光淋巴造影的使用受设备可用性影响,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fluorescent lymphography is an excellent technique for complete lymph node dissection during minimally invasive surgery for gastric cancer. This study aimed to evaluate the role of fluorescent lymphography in splenic hilar lymph node dissection during minimally invasive total gastrectomy. METHODS: We retrospectively analyzed 168 gastric cancer patients who underwent minimally invasive total gastrectomy with D2 + No. 10 lymph node dissection from 2013 to 2018. Fluorescent lymphography was used whenever it is possible. However, when near-infrared imaging system and endoscopic indocyanine green injection were not available, we performed surgery without fluorescent lymphography. A total of 74 patients underwent surgery with fluorescent lymphography (FL group) and 94 underwent surgery without it (non-FL group). Perioperative and long-term outcomes including the number of retrieved lymph nodes at each nodal station were compared between groups. RESULTS: The median number of retrieved lymph nodes at the splenic hilum was larger in the FL group {2.5 [Interquartile range (IQR), 1-5]} than in the non-FL group [1 (IQR, 1-3); P = 0.012]. The negative predictive value of fluorescent lymphography for lymph node metastasis at the splenic hilum was 97.1%, although the sensitivity was 66.7%. The overall survival (FL: 96.9% vs. non-FL: 88.9%; P = 0.334) and relapse-free survival (FL: 90.5% vs. non-FL: 65.5%; P = 0.054) were higher in the FL group, although there were no statistical differences. However, among the patients without lymph node metastasis, the relapse-free survival was significantly higher in the FL group (100%) than in the non-FL group (67.1%; P = 0.017). CONCLUSIONS: Fluorescent lymphography is an effective tool for complete lymph node dissection at the splenic hilum. Moreover, it may help select patients who do not need splenic hilar lymph node dissection during a total gastrectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lee S, Song JH, Choi S, et al. Fluorescent lymphography during minimally invasive total gastrectomy for gastric cancer: an effective technique for splenic hilar lymph node dissection. Surg Endosc. 2021. PMID: 34109482. doi:10.1007/s00464-021-08584-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。